Literature DB >> 30096583

Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke.

Qianyi He1, Xiaojuan Shi2, Bin Zhou3, Junfang Teng4, Chaoqi Zhang2, Shasha Liu3, Jingyao Lian3, Benyan Luo5, Guoqiang Zhao6, Hong Lu4, Yuming Xu4, Yajun Lian4, Yanjie Jia4, Yi Zhang7.   

Abstract

Granulocytes and natural killer (NK) cells have been linked to brain injury in ischemic stroke. However, their recruitment from peripheral leucocytes in stroke patients is not well understood. Here, the expression of the interleukin 8 (CXCL8) in plasma, and CXC chemokine receptor 2 (CXCR2) in peripheral leucocytes of patients with ischemic stroke were evaluated. Based on the results, CXCR2 expression positively correlated with granulocytes and NK cells, which were in turn attracted by CXCL8. The results also indicated that CXCR2 was a direct target of microRNA (miR)-4437, a negative regulator of CXCR2, which was downregulated in peripheral leucocytes from patients with ischemic stroke. Furthermore, serum CXCL8 levels were associated with the infarct volume and functional outcomes in patients with ischemic stroke. The results of the receiver operating characteristic curve analysis with an optimal cut-off value of 34 pg/mL indicated serum CXCL8 levels could be a prognostic indicator for ischemic stroke. In conclusion, these data highlighted the involvement of the CXCL8-CXCR2 chemotactic axis in the recruitment of granulocytes and NK cells in ischemic stroke. Furthermore, miR-4437 was suggested as a novel target for treating ischemic stroke, while the serum CXCL8 level could be a prognostic factor for ischemic stroke.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CXCR2-CXCL8; Granulocytes; Ischemic stroke; Natural killer cells; Prognosis; microRNA

Mesh:

Substances:

Year:  2018        PMID: 30096583     DOI: 10.1016/j.molimm.2018.08.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.

Authors:  Matthew C Morris; Katherine E Cooney; Hooman Sedghamiz; Maria Abreu; Fanny Collado; Elizabeth G Balbin; Travis J A Craddock; Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Clin Ther       Date:  2019-03-28       Impact factor: 3.393

2.  Assessment of Interleukin-8 in Bronchial Asthma in Iraq.

Authors:  M Faeqali Jan; H Muneer Al-Khafaji; B Hasan Al-Saadi; M K Aneed Al-Saedi
Journal:  Arch Razi Inst       Date:  2021-10-31

3.  Key Phytochemicals and Biological Functions of Chuanxiong Rhizoma Against Ischemic Stroke: A Network Pharmacology and Experimental Assessment.

Authors:  Peng Zeng; Yao Yi; Hong-Fei Su; Chao-Yuan Ye; Yi-Wen Sun; Xin-Wen Zhou; Youming Lu; Anbing Shi; Qing Tian
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

Review 4.  The Role of Immune Cells in Post-Stroke Angiogenesis and Neuronal Remodeling: The Known and the Unknown.

Authors:  Yinzhong Ma; Shilun Yang; Qianyan He; Dianhui Zhang; Junlei Chang
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

Review 5.  CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.

Authors:  Jan Korbecki; Patrycja Kupnicka; Mikołaj Chlubek; Jarosław Gorący; Izabela Gutowska; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

6.  Identification of pyroptosis-related immune signature and drugs for ischemic stroke.

Authors:  Shanshan Shi; Qi Zhang; Changda Qu; Yushi Tang; Yewei Qu; Shirong Wen; Ruohan Sun; Yujun Pan
Journal:  Front Genet       Date:  2022-09-27       Impact factor: 4.772

7.  Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury.

Authors:  Liquan Wu; Xiaoxing Xiong; Xiaomin Wu; Yingze Ye; Zhihong Jian; Zeng Zhi; Lijuan Gu
Journal:  Front Mol Neurosci       Date:  2020-03-05       Impact factor: 5.639

8.  Natural Killer Cells Are Present in Rag1-/- Mice and Promote Tissue Damage During the Acute Phase of Ischemic Stroke.

Authors:  Leoni Rolfes; Tobias Ruck; Christina David; Stine Mencl; Stefanie Bock; Mariella Schmidt; Jan-Kolja Strecker; Steffen Pfeuffer; Andreas-Schulte Mecklenbeck; Catharina Gross; Michael Gliem; Jens Minnerup; Michael K Schuhmann; Christoph Kleinschnitz; Sven G Meuth
Journal:  Transl Stroke Res       Date:  2021-06-08       Impact factor: 6.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.